Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam

AIDS Research and Human Retroviruses

Volumn 28, Issue 8, 2012, Pages 866-873

  Sexton, Connie J ^a,c   Costenbader, Elizabeth C ^a   Vinh, Dang Thi Nhat ^a   Chen, Pai Lien ^a   Hoang, Tran Vu ^a   Lan, Nguyen Thi Hoang ^b   Feldblum, Paul ^a   Kim, Andrea ^c   Giang, Le Truong ^d  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b CPM   (Viet Nam)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d PAC   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; OPIATE;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; VIET NAM;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; VIETNAM; YOUNG ADULT;

EID: 84864244701     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0221     Document Type: Article

References (25)

1. Karim QA, Karim S, et al. on behalf of the CAPRISA 004 Trial Group: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-1174.
2. Grant RM, Lama JR, Anderson PL, et al.: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-2599.
3. Auvert B, Taljaard D, Lagarde E, et al.: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005;2:e298.
4. Bailey RC, Moses S, Parker CB, et al.: Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 2007;369:643-656.
5. Cohen MS, Chen YQ, McCauley M, et al.: Prevention of HIV- 1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
6. Busch MP, Pilcher CD, Mastro TD, et al.: Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010;24:2763-2771.
7. Mastro TD, Kim AA, Hallett T, et al.: Estimating HIV incidence in populations using tests for recent infection: Issues, challenges and the way forward. J HIV/AIDS Surveillance Epidemiol 2010;2:7.
8. Hall HI, Song R, Rhodes P, et al.: Estimation of HIV incidence in the United States. JAMA 2008;300:520-529.
9. Jiang Y, Wang M, Ni M, et al.: HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS 2007;21(SUPPL 8):S47-S51.
10. Saphonn V, Parekh BS, Dobbs T, et al.: Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999-2002. J Acquir Immune Defic Syndr 2005; 39:587-592.
11. Wolday D, Meles H, Hailu E, et al.: Temporal trends in the incidence of HIV infection in antenatal clinic attendees in Addis Ababa, Ethiopia, 1995-2003. J Intern Med 2007;261:132-137.
12. Rehle T, Shisana O, Pillay V, et al.: National HIV incidence measures-new insights into the South African epidemic. S Afr Med J 2007;97:194-199.
13. Mermin J, Musinguzi J, Opio A, et al.: Risk factors for recent HIV infection in Uganda. JAMA 2008;300:540-549.
14. Hladik W, Olara D, Mermin J, et al.: Effect of CD4( + ) T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses [Epub ahead of print]; DOI: 10.1089/aid.2010.0347.
15. Marinda ET, Hargrove J, Preiser W, et al.: Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr 2010;53:496-499.
16. McDougal JS, Parekh BS, Peterson ML, et al.: Comparison of HIV type 1 incidence observed during longitudinal followup with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006;22:945-952.
17. Hargrove JW, Humphrey JH, Mutasa K, et al.: Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008;22:511-518.
18. Welte A, McWalter TA, and Barnighausen T: A simplified formula for inferring HIV incidence from cross-sectional surveys using a test for recent infection. AIDS Res Hum Retroviruses 2009;25:125-126.
19. Suligoi B, Galli C, Massi M, et al.: Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 2002;40:4015-4020.
20. Suligoi B, Butto S, Galli C, et al.: Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity. J Clin Virol 2008;41: 288-292.
21. Parekh BS, Kennedy MS, Dobbs T, et al.: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18:295-307.
22. Parekh BS, Hanson DL, Hargrove J, et al.: Determination of mean recency period for estimation of HIV type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 2011;27:265-273.
23. Pilcher CD, McPherson JT, Leone PA, et al.: Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA 2002;288:216-221.
24. Office of the Global AIDS Coordinator (OGAC): Update on HIV-1 incidence estimation and surveillance in resourceconstrained settings using tests for recent infection-statement from the surveillance and survey and the laboratory technical working groups to the office of the global AIDS coordinator, September 2010. OGAC, Washington DC, 2010.
25. Tuan NA, Le L, Shah N, and Kim AA: Validation study of HIV-1 incidence assays in Vietnam. The second Asia Regional HIV Surveillance Meeting, Lessons learned in second generation surveillance: the Asia experience. Ho Chi Minh City, Vietnam, 2010.